Nadia brings more than 16 years of experience in global regulatory affairs. Before joining Arvelle, she was responsible for the EU Regulatory strategy at Sage Therapeutics GmbH. Prior to that, she led the local EMEA Regulatory teams at Alexion Pharmaceuticals GmbH, focusing on ultra rare conditions. Throughout her career, Nadia spearheaded multiple regulatory submissions and led the global regulatory strategy across different therapeutic areas. She started her career at Novartis Pharma GmbH and later supported the EU business setup of Cubist Pharmaceuticals Inc.
Nadia holds a Master of Pharmacy from the University of Medicine in Sofia (Bulgaria), an M.B.A. from the University of Strathclyde, Glasgow (UK), an M.Sc. in Health Policy from Imperial College London (UK), and an LL.M with specialization in International Business Law from University of London (UK).